P

Active Director Director DIN 08781045
DIN 08781045 First appointment Jul 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Priyanka

Data last updated:

Priyanka is a Director at Best Care Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Best Care Pharmaceuticals Private Limited reported revenue of ₹1.4 Lakh (FY 2024).

DIN 08781045
Primary Designation Director
Industry Chemicals
First Appointment 24 Jul 2020
Oldest Company Age 6 yrs
Largest company Best Care Pharmaceuticals Private Limited · ₹1.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jul 20202020₹1.4 Lakh (FY 2024)Active

Board colleagues of Priyanka

NameDINCompanyDesignation
Vandana Tyagi08781041Best Care Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Best Care Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Priyanka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka

Priyanka currently holds 1 directorship: Best Care Pharmaceuticals Private Limited (Director, since 24 Jul 2020, revenue ₹1.4 Lakh (FY 2024)).

Priyanka was first appointed on 24 Jul 2020 as Director at Best Care Pharmaceuticals Private Limited.

The current boards of Priyanka's companies include Vandana Tyagi (Best Care Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available